Skip to main content
Jerome Ritz, MD, Hematology, Boston, MA

JeromeRitzMD

Hematology • Boston, MA

Hematologic Oncology

Professor of Medicine, Dana-Farber Cancer Institute

Join to view full profile

Dr. Ritz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ritz's full profile

Already have an account?

  • Office

    450 Brookline Ave
    M530, Dana-Farber Cancer Institute
    Boston, MA 02215
    Phone+1 617-632-3465
    Fax+1 617-632-5167

Summary

  • Dr. Jerome Ritz is a hematologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital and Dana-Farber Cancer Institute. He is Professor of Medicine at Harvard Medical School. He received his medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice 45 years. He specializes in hematologic oncology and is experienced in hematologic oncology, hematopoietic stem cell transplantation and cellular therapies. He is currently Executive Director of the Connell and O'Reilly Families Cell Manipulation Core Facility.

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1972 - 1975
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1972
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1976 - 2025
  • CO State Medical License
    CO State Medical License 1975 - 1980
  • WI State Medical License
    WI State Medical License 1973 - 1979
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Elected Member Association of American Physicians, 2021
  • Elected Member The American Society for Clinical Investigation, 1990
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Journal Articles

  • Small-Molecule BCL6 Inhibitor Effectively Treats Mice with Non-Sclerodermatous Chronic Graft-Versus-Host Disease  
    Joseph H Antin, Bruce Blazar, Leo Luznik, John Koreth, Ivan Maillard, Robert J Soiffer, James E Bradner, Jonathan S Serody, Jerome Ritz, Blood
  • Immunophenotyping of Pediatric Brain Tumors: Correlating Immune Infiltrate with Histology, Mutational Load, and Survival and Assessing Clonal T Cell Response  
    Isaac H Solomon, Mark W Kieran, Gabriel K Griffin, Pratiti Bandopadhayay, Jerome Ritz, Ashley S Plant, Keith L Ligon, Glenn Dranoff, Journal of Neuro-Oncology

Abstracts/Posters

  • Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizu...
    Jerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Graft Failure after Haploidentical Hematopoietic Stem Cell Transplantation
    Jerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T Cells
    Jerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Gut Bacteria Engineered to Act as Tumor GPS for Immunotherapies
    Gut Bacteria Engineered to Act as Tumor GPS for ImmunotherapiesOctober 4th, 2024
  • New Research Offers Hope for Safer and More Effective Blood Stem Cell Transplants
    New Research Offers Hope for Safer and More Effective Blood Stem Cell TransplantsSeptember 4th, 2024
  • National Cancer Center Is Pleased to Name David Knorr, M.D., Ph.D., to Scientific Advisory Board
    National Cancer Center Is Pleased to Name David Knorr, M.D., Ph.D., to Scientific Advisory BoardOctober 25th, 2022
  • Join now to see all

Professional Memberships

Dr. Jerome Ritz, Dr. Jerome Ritz, MD, Dr. J Ritz